Notice ID: d914f9464ef44409b02b4b3dd61d0088Solicitation
LASSA FEVER VIRUS (LASV) CELL SORTING FOR MONOCLONAL ANTIBODY DISCOVERY FOR USAMRIID - AMENDMENT 0001 - QUESTIONS FROM OFFERORS
Archived on June 28, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 1:00 PM UTC−04:00
- Posted
- June 29, 2023
- Notice type
- Solicitation
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of WarDEFENSE HEALTH AGENCY (DHA)
Notice details
- Office
- ARMY MED RES ACQ ACTIVITY
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- HT942523Q0059
- Notice ID
- d914f9464ef44409b02b4b3dd61d0088
Description
This is a combined synopsis/solicitation for commercial services prepared in accordance with FAR 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, as supplemented with additional information included in this notice and FAR 13, Simplified Acquisition Procedures. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number is HT942523Q0059. The solicitation is issued as a Request for Proposal (RFP). Provisions and clauses in effect through Federal Acquisition Circular 2023-04 are incorporated. It is the contractor?s responsibility to be familiar with the applicable clauses and provisions. The clause may be access in full text at: https://www.acquisition.gov/.The associated North American Industrial Classification System (NAICS) code for this procurement is 541380, with a small business size standard of $19.0M. This action is set-aside 100% for small businesses.The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) has a requirement for a contract that provides for severable, non-personal services to sort peripheral blood mononuclear cells (PBMCs) from Lassa fever virus (LASV) survivors to discover and produce monoclonal antibodies for assessment in in-vitro and in-vivo assays at USAMRIID. Successful antibody discovery pipelines depend on: (1) the source sample used for antibody discovery, (2) the availability of high-quality antigens to identify and down-select candidate Monoclonal antibodies (mAbs), and (3) a detailed understanding of the underlying biology of the target. The contract, awarded as a result of this solicitation, will consist of one, 12-month base period and two, 12-month option periods for a total of 36 months.The U.S. Army Medical Research Acquisition Activity (USAMRAA) requests responses from qualified sources capable of providing services outlined in the Performance Work Statement (PWS). Please refer to attached solicitation for additional details and instructions.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
HT942523Q0059- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- 2×SolicitationCurrentJun 22, 2023
LASSA FEVER VIRUS (LASV) CELL SORTING FOR MONOCLONAL ANTIBODY DISCOVERY FOR USAMRIID - AMENDMENT 0001 - QUESTIONS FROM OFFERORS
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
HT942523Q0059
Archive Date
Jun 28, 2024
Office Address
FORT DETRICK, MD, 21702